Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System?
The case of Andrew Gobea, the first child to receive experimental gene therapy for SCID, and a reflection on the associated ethical implications of gene therapy research.
Main Author: | Williams-Jones, Bryn |
---|---|
Format: | Article |
Language: | English |
Published: |
BioéthiqueOnline
2012-03-01
|
Series: | BioéthiqueOnline |
Subjects: | |
Online Access: | http://bioethiqueonline.ca/1/4 |
Similar Items
-
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care
by: Marian L. Henderson, et al.
Published: (2024-01-01) -
Differences and similarities between cancer and somatic stem cells: therapeutic implications
by: Fiorella Rossi, et al.
Published: (2020-11-01) -
Group‐based Acceptance and Commitment Therapy (AHEAD) for adolescents with multiple functional somatic syndromes: A randomised trial
by: Karen Hansen Kallesøe, et al.
Published: (2021-12-01) -
Augmentation Therapies as Treatments for Coexisting Somatic Problems in Schizophrenia—A Systematic Review
by: Wiktor Dróżdż, et al.
Published: (2023-06-01) -
Translational Benefits of Gene Therapy to Date
by: M Mary McMenamin
Published: (2011-03-01)